PACB News and Press, Pacific Biosciences of California Inc. From 08/02/23

2023-08-02 20:57:05 ET Pacific Biosciences of California, Inc. (PACB) Q2 2023 Earnings Conference Call August 02, 2023, 05:00 PM ET Company Participants Todd Friedman - Director, Investor Relations Christian Henry - President and Chief Executive Officer Susan Kim...

2023-08-02 16:11:56 ET Pacific Biosciences of California press release ( NASDAQ: PACB ): Q2 Non-GAAP EPS of -$0.26 beats by $0.05 . Revenue of $47.57M (+34.0% Y/Y) beats by $7.66M . Recognized revenue on 47 sequencing systems in the second quarter, including 45...

PacBio Announces Second Quarter 2023 Financial Results PR Newswire MENLO PARK, Calif. , Aug. 2, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2023 . Second quarter results ...

PacBio Enters into Agreement to Acquire Apton Biosystems to Accelerate the Development of a Next Generation, High Throughput, Short-read Sequencer PR Newswire PacBio will Combine Apton's Proprietary Sequencing Technology With its Highly Accurate Sequencing by Binding Chemist...

PacBio Begins Commercialization of the Onso Short-Read Sequencing System PR Newswire The Onso Platform Delivers Extraordinary Accuracy Which Creates New Possibilities for Research and Translational Sequencing Applications MENLO PARK, Calif. , Aug. 2, 2023 /PR...

PacBio to Report Second Quarter 2023 Financial Results on August 2, 2023 PR Newswire MENLO PARK, Calif. , July 19, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2023 financ...

2023-07-15 04:25:01 ET Summary The memo reads that the bear market has been cancelled, and there are few who are as happy about the change in fortunes as Cathie Wood and ARK Funds. Her flagship ARKK fund, as well as other ARK family funds, have had an impressive run lately and wer...

2023-07-10 14:30:37 ET Summary Illumina and Pac Bio are two of the best known next-generation DNA sequencing companies. Illumina is by far the larger company - it tried to acquire Pac Bio back in 2020, but the deal was abandoned on anti-competitive grounds. Pac Bio has coveted...

PacBio's Revio System Empowers Bioscientia to Scale Long-Read Whole Genome Sequencing and Unravel the Mysteries of Rare Disease PR Newswire Bioscientia Acquires Multiple Revio Sequencing Systems to Revolutionize Rare Disease Research by Sequencing Thousands of Long-Read Human ...

2023-06-26 10:19:36 ET Pacific Biosciences of California ( NASDAQ: PACB ) entered into a privately negotiated exchange agreement with a certain noteholder, the company said Monday. Under the exchange agreement, PacBio will issue $441 million of its 1.375% convertible s...